Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410195 | Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Peng Li, Robert E. Davis | 2025-09-09 |
| 12365650 | Deuterated organic compounds and uses thereof | Krishna VADODARIA, Vikram SUDARSAN, David S. Garvey | 2025-07-22 |
| 12325726 | Organic compounds | Peng Li, Robert E. Davis, Yupu QIAO | 2025-06-10 |
| 12195463 | Organic compounds | Peng Li, Robert E. Davis | 2025-01-14 |
| 12194042 | Uses | Robert E. Davis | 2025-01-14 |
| 12173004 | Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs | Peng Li, Hailin Zheng, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2024-12-24 |
| 12122792 | Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Peng Li, Robert E. Davis | 2024-10-22 |
| 12090155 | Methods | Sharon Mates, Robert E. Davis | 2024-09-17 |
| 11958852 | Compounds and methods | Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2024-04-16 |
| 11844757 | Organic compounds | Wei Yao, Peng Li, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2023-12-19 |
| 11773095 | Organic compounds | Peng Li, Hailin Zheng, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2023-10-03 |
| 11753419 | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Peng Li, Robert E. Davis | 2023-09-12 |
| 11427587 | Organic compounds | Peng Li, Hailin Zheng, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2022-08-30 |
| 11376249 | Organic compounds | Peng Li, Wei Yao, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2022-07-05 |
| 11124514 | Compositions and methods | Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2021-09-21 |
| 11053245 | Methods | Sharon Mates, Robert E. Davis | 2021-07-06 |
| 11026951 | Methods of treating bipolar disorder | Peng Li, Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2021-06-08 |
| 10960009 | Methods of treating schizophrenia and depression | Peng Li, Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2021-03-30 |
| 10960010 | Pharmaceutical compositions for sustained or delayed release | Peng Li, Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2021-03-30 |
| 10799500 | Organic compounds | Wei Yao, Peng Li, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2020-10-13 |
| 10322134 | Methods | Peng Li, Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2019-06-18 |
| 10245260 | Organic compounds | Wei Yao, Peng Li, Robert E. Davis, Sharon Mates, Gretchen SNYDER | 2019-04-02 |
| 9956227 | Method for the treatment of residual symptoms of schizophrenia | Peng Li, Sharon Mates, Robert E. Davis, Lawrence P. Wennogle | 2018-05-01 |
| 9428506 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders | Sharon Mates, Robert E. Davis, Peng Li, Lawrence P. Wennogle | 2016-08-30 |